What is Trident Texofab Ltd (540726) share price return in the past 10 years?

Data is not available for this company

What is the share price of Trident Texofab Ltd (540726)?

Company share prices are keep on changing according to the market conditions. The current trading price of Trident Texofab Ltd (540726) on 10-Apr-2026 16:59:59 at 16:59 is 57.92.

What is the P/E ratio of Trident Texofab?

The latest standalone P/E ratio of Trident Texofab as of 10-Apr-2026 is 26.95.

What is the P/B ratio of Trident Texofab Ltd (540726)?

The latest standalone P/B ratio of Trident Texofab Ltd (540726) as of 10-Apr-2026 is 1.51.

What is the 52-week high and low of Trident Texofab Ltd (540726)?

The 52-week high of Trident Texofab Ltd (540726) is Rs. 379.00 and the 52-week low is Rs. 38.57.

Trident Texofab Ltd (540726) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Trident Texofab Ltd (540726)
Brand: Trident Texofab

Trident Texofab Ltd (540726) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹87 Cr.

P/E Ratio

26.95

Price to Book (P/B)

1.51

Price to Sales (P/S)

0.71

EV/EBITDA

12.35

Return on Capital Employed (ROCE)

11.43%

Current Price

₹57.9

Return on Equity (ROE)

8.46%

Return on Assets (ROA)

2.75%

Operating Profit Margin

4.6%

Net Profit Margin

2.06%

Gross Profit Margin

3.4%

Book Value per Share

₹38.3

Sales Growth (YoY)

22.7%

Sales Growth (3 Years)

13.14%

Operating Profit Growth (1 Year)

-10.69%

Operating Profit Growth (3 Years)

5.35%

Net Profit Growth (1 Year)

132.41%

52-Week Low / High

₹39 / 379

Net Profit Growth (3 Years)

36.7%

Dividend Yield

0.00%

Promoter Holding

32.16%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1

Trident Texofab Ltd belongs to the Textiles & Apparels sector, operating specifically within the Textile segment.

Q.1 Gross Profit margin of Trident Texofab Ltd?

Trident Texofab Ltd Gross profit margin which is the profit after deduction of direct costs, is 3.4% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.

Q.1 Promoter shareholding and pledge status of Trident Texofab Ltd?

Promoters hold 32.16% of the Trident Texofab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Trident Texofab Ltd vs industry peers?

Trident Texofab Ltd revenue CAGR is 6.06% , compared to the industry median CAGR of -35.05% , indicating faster growth and gaining its market share.

Q.1 Stock return of Trident Texofab Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.

Q.1 Is Trident Texofab Ltd a good quality company?

Trident Texofab Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Trident Texofab

Based on:

Data

M-Cap below 100cr DeciZen not available

Trident Texofab stock performance

Key Ratios

Is Trident Texofab Ltd an attractive stock to invest in?

1. Is Trident Texofab Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Trident Texofab Ltd is a below average quality company.

2. Is Trident Texofab Ltd undervalued or overvalued?

The key valuation ratios of Trident Texofab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Trident Texofab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trident Texofab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	9.9%	15.9%	16.1%	13.1%	14.3%	9.8%	9%	13.1%	10.3%	11.4%	-
Value Creation Index ⓘ	-0.3	0.1	0.2	-0.1	0.0	-0.3	-0.4	-0.1	-0.3	-0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	66	76	85.5	86.9	91	49.9	84.3	96.4	99.5	122	123
Sales YoY Gr.	-	15.1%	12.5%	1.7%	4.7%	-45.1%	68.9%	14.3%	3.2%	22.7%	-
Adj EPS ⓘ	2.6	4	0.6	1.2	1	0.3	0.9	2.3	0.9	0.7	2.2
YoY Gr.	-	57%	-84.1%	90.6%	-21.3%	-69.8%	220.7%	146.2%	-62.9%	-22.4%	-
BVPS (₹) ⓘ	43.5	47.6	8.6	11	11.8	11.9	12.8	15.1	16.1	31.8	38.3
Adj Net Profit ⓘ	0.2	0.3	0.6	1.2	0.9	0.3	0.9	2.3	0.9	0.9	3
Cash Flow from Ops. ⓘ	0.7	0.1	-2.5	-2.8	-2.9	2	1.4	5.9	2.7	-13.7	-
Debt/CF from Ops. ⓘ	4.3	41.1	-2.1	-5.4	-7.8	15.9	25.6	5.9	13.6	-1.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.1%	6.1%	13.1%	22.7%
Adj EPS ⓘ	-14%	-7.2%	-10.8%	-22.4%
BVPSⓘ	-3.4%	22%	35.3%	97%
Share Price	-	16.5%	-6.2%	-66%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	5.9	8.8	10.2	12.2	8.2	2.5	7.5	16.4	5.5	2.8	6.1
Op. Profit Mgn % ⓘ	1.5	1.5	1.7	2.8	5.3	5.8	5.7	6.6	6.3	4.6	6.2
Net Profit Mgn % ⓘ	0.3	0.4	0.7	1.4	1	0.6	1.1	2.4	0.9	0.7	2.6
Debt to Equity ⓘ	0.9	1.4	0.6	1.4	1.9	2.6	2.8	2.3	2.3	0.6	-
Working Cap Days ⓘ	173	136	126	152	147	304	185	176	194	196	106
Cash Conv. Cycle ⓘ	22	3	18	29	61	136	98	98	105	109	51

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 13.14%

Debt to equity has declined versus last 3 years average to 0.62

Return on Equity has declined versus last 3 years average to 6.10%

Net Profit has been subdued in last 3 years -10.80%

Sales growth is not so good in last 4 quarters at 8.23%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2.2	-
TTM Sales (₹ Cr.)	123	-
BVPS (₹) ⓘ	38.3	-
Reserves (₹ Cr.) ⓘ	43	-
P/BV ⓘ	1.51	-
PE ⓘ	26.95	-

From the Market
52 Week Low / High (₹)	38.57 / 379.00
All Time Low / High (₹)	13.33 / 379.00
Market Cap (₹ Cr.)	86.9
Equity (₹ Cr.)	15
Face Value (₹)	10
Industry PE ⓘ	32.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Trident Texofab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	65.98	75.95	85.46	86.90	90.96	49.91	84.29	96.36	99.48	122.06
Operating Expenses ⓘ +	64.99	74.80	84.01	84.50	86.14	47.03	79.50	90.05	93.22	116.46
Manufacturing Costs	0	0.32	0.42	0.70	2.41	0.91	1.56	3	2.77	3.57
Material Costs	62.82	72.38	81.97	79.51	78.78	42.06	72.26	80.39	83.83	105.82
Employee Cost	0.90	0.66	0.67	1.59	2.11	1.71	2.06	2.40	2.28	2.32
Other Costs ⓘ	1.28	1.44	0.95	2.70	2.83	2.35	3.63	4.26	4.34	4.75
Operating Profit ⓘ	0.99	1.15	1.45	2.40	4.83	2.88	4.79	6.31	6.27	5.60
Operating Profit Margin (%)	1.5%	1.5%	1.7%	2.8%	5.3%	5.8%	5.7%	6.5%	6.3%	4.6%
Other Income ⓘ +	0.05	0.24	0.48	0.32	0.42	1.85	0.74	1.90	0.39	3.30
Exceptional Items ⓘ	-0.21	-0.02	0	0.14	-0	0.05	0.04	-0.13	0.31	0
Interest ⓘ	0.60	0.68	0.77	0.86	2.71	2.85	2.83	3.71	4.15	4.68
Depreciation ⓘ	0.14	0.13	0.13	0.30	1.01	1.02	1.47	1.64	1.65	1.65
Profit Before Tax ⓘ	0.09	0.56	1.04	1.69	1.53	0.90	1.27	2.73	1.17	2.58
Tax ⓘ	0.03	0.23	0.29	0.42	0.63	0.55	0.29	0.51	0.09	0.07
Profit After Tax	0.06	0.33	0.75	1.27	0.90	0.35	0.98	2.22	1.08	2.51
PAT Margin (%)	0.1%	0.4%	0.9%	1.5%	1.0%	0.7%	1.2%	2.3%	1.1%	2.1%
Adjusted EPS (₹)	0.1	0.5	0.8	1.3	0.9	0.4	1.0	2.2	1.1	1.9
Dividend Payout Ratio (%)	0%	0%	53%	31%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3.46	3.79	8.26	11	11.62	11.98	12.96	15.18	16.26	43.13
Share Capital ⓘ	0.33	0.33	4	4.20	4.20	10.07	10.07	10.07	10.07	13.56
Reserves ⓘ	3.13	3.46	4.27	6.80	7.43	1.91	2.89	5.11	6.19	29.57
Debt +	2.98	5.18	4.17	12.85	20.37	29.15	33.40	31.72	33.98	23.68
Long Term Debt	0.51	5.18	4.17	9.25	10.55	19.19	20.27	18.58	17.74	7.43
Short Term Debt	2.47	0	0	3.60	9.81	9.96	13.13	13.14	16.24	16.25
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	30.80	14.84	30.31	19.39	16.03	16.22	11.39	17.62	16.69	14.86
Others Liabilities ⓘ	0.74	0.67	2.20	3.81	7.66	10.43	13.24	12.79	14.97	18.91
Total Liabilities ⓘ	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31	81.90	100.58
Fixed Assets
Net Fixed Assets ⓘ +	1.33	1.25	1.56	2.36	12.48	14.21	21.71	23.33	21.74	20.08
Gross Block	1.72	1.73	2.17	3.27	14.18	16.75	25.43	28.56	28.46	28.33
Accumulated Depreciation	0.39	0.48	0.61	0.91	1.70	2.54	3.72	5.23	6.73	8.24
CWIP ⓘ	0	0	0	6.39	0.30	8.89	3.62	0	0	0
Investments ⓘ	0.33	0.82	2.65	1.42	1.12	2.48	2.06	3.64	3.74	1.89
Inventories	9.38	2.31	5.07	3.93	10.11	8.01	7.27	10.64	13.55	15.96
Trade Receivables	26.03	15.40	32.13	29.40	26.43	30.28	30.85	33.87	36.67	40.71
Cash Equivalents	0.16	1.86	0.23	0.39	0.08	0.03	0.04	0.06	0.16	3.16
Others Assets ⓘ	0.76	2.85	3.29	3.16	5.15	3.86	5.43	5.76	6.04	18.77
Total Assets ⓘ	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31	81.90	100.58

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.70	0.13	-2.45	-2.75	-2.85	1.96	1.39	5.85	2.71	-13.72
PBT ⓘ	0.09	0.56	1.04	1.69	1.53	0.90	1.27	2.73	1.17	2.58
Adjustment ⓘ	0.08	0.12	0.13	1.24	3.68	2.92	4.64	4.33	5.79	3.82
Changes in Working Capital ⓘ	0.61	-0.38	-3.19	-4.94	-7.56	-1.63	-4.52	-1.07	-4.13	-19.81
Tax Paid ⓘ	-0.08	-0.17	-0.41	-0.74	-0.50	-0.23	0	-0.13	-0.12	-0.30
Cash Flow From Investing Activity ⓘ +	-0.10	-0.54	-2.27	-6.61	-2.41	-10.19	-4.38	0.37	-0.57	4.50
Capex	0.24	-0.05	-0.44	-7.60	-1.63	-9.92	-3.80	-0.22	-0.03	0
Net Investments	-0.32	-0.49	-1.83	0.99	-0.83	-0.09	-0.57	-0.10	-0.47	4.33
Others ⓘ	-0.02	0	-0	-0	0.05	-0.19	-0.01	0.69	-0.07	0.17
Cash Flow From Financing Activity ⓘ +	-0.63	2.11	3.09	9.59	4.95	8.19	2.99	-6.20	-2.05	12.23
Net Proceeds from Shares ⓘ	0	0	4.48	2.03	0	0	0	0	0	52.95
Net Proceeds from Borrowing ⓘ	-0.63	4.58	-1.02	5.08	1.94	9.19	1.49	-3.16	-1.13	-10.32
Interest Paid ⓘ	0	0	0	-0.86	-2.41	-2.73	-2.22	-3.39	-3.78	-4.31
Dividend Paid ⓘ	0	0	0	-0.08	-0.41	0	0	0	0	0
Others ⓘ	0	-2.47	-0.38	3.42	5.84	1.72	3.72	0.36	2.86	-26.10
Net Cash Flow ⓘ	-0.02	1.69	-1.62	0.22	-0.31	-0.05	0	0.02	0.09	3

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	1.7	9.07	12.44	13.56	8.25	3.04	7.91	15.8	6.88	8.46
ROCE (%)	9.87	15.9	16.1	13.12	14.28	9.8	8.95	13.07	10.32	11.43
Asset Turnover Ratio	1.99	2.43	2.55	2	1.87	0.82	1.22	1.31	1.26	1.35
PAT to CFO Conversion(x)	11.67	0.39	-3.27	-2.17	-3.17	5.6	1.42	2.64	2.51	-5.47
Working Capital Days
Receivable Days	124	100	98	122	106	206	132	122	128	115
Inventory Days	44	28	15	18	27	66	33	34	44	44
Payable Days	149	115	101	114	82	140	70	66	75	54

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Trident Texofab Ltd FAQs

The current trading price of Trident Texofab on 10-Apr-2026 16:59 is ₹57.92.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Trident Texofab stood at ₹86.86 Cr

The latest P/E ratio of Trident Texofab as of 09-Apr-2026 is 26.95.

The latest P/B ratio of Trident Texofab as of 09-Apr-2026 is 1.51.

The 52-week high of Trident Texofab is ₹379.0 and the 52-week low is ₹38.57.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Texofab is ₹123 ( Cr.) .

About Trident Texofab Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Trident Texofab Ltd (540726) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Trident Texofab Share Price